StocksDeepDive
Snapshot · Foreign US-listed · generated 2026-11-11 20:45 UTC

RDY — Dr. Reddy's Laboratories Limited

EXPENSIVE (MOS -125.9%) · Quality 51/100

Price
14.77
Intrinsic value
6.54
Margin of safety
-125.9%
Implied growth (reverse DCF)
+29.7%
model assumes +14.2%
Value Score
0.1
Quality
51
Psychology
-26.5
Discovery
5.2
price/volume attention only
Moat score
38.8
erosion: watch

Value Score: bottom 2% of Foreign US-listed · Quality: bottom 26%

Dividend: 0.083/share (TTM) · yield 0.6% · payout 23%

Open the interactive Deep Dive for RDY →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/RDY - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

Is RDY undervalued?

As of 2026-11-11, RDY trades at 14.77 against a computed intrinsic value of 6.54 (-125.9% margin of safety) - StocksDeepDive's valuation label for this is EXPENSIVE. This is a described calculation from public data, not a recommendation.

What is Dr. Reddy's Laboratories Limited's Value Score?

Dr. Reddy's Laboratories Limited's Value Score is 0.1 as of 2026-11-11 - it combines value, quality, crowd psychology and market attention into one number.

Does RDY pay a dividend?

Yes - RDY's trailing twelve-month dividend is 0.083/share, a yield of 0.6% at the current price (as of 2026-11-11).